Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

ABPI's Richard Barker to step down in light of new UK reimbursement negotiations

This article was originally published in Scrip

Executive Summary

Dr Richard Barker, the director general of the UK R&D industry association, the ABPI, is to step down in May 2011 after six years in the post, to let a successor take over the lengthy negotiations that are expected with the UK's coalition government when it introduces value-based pricing (VBP) to replace the Pharmaceutical Price Regulation Scheme (PPRS) in 2014.

Latest Headlines
See All
UsernamePublicRestriction

Register

SC010407

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel